Fingerprint
Dive into the research topics of 'Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b: Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically